Retatrutide Peptide Canada (Retatrutide– 20mg)

Retatrutide Peptide Canada (LY-3437943), a synthetic triple GLP-1/GIP/glucagon receptor agonist peptide studied for advanced metabolic research. 20mg lyophilized powder, 99%+ purity verified by Janoshik Analytical via HPLC and mass spectrometry. CAS 2381089-83-2.

• For laboratory research use only.

• Not for human or veterinary use.

• Not intended for diagnosis, treatment, cure, or prevention of any disease.

• Use only in controlled laboratory settings by qualified personnel following appropriate safety procedures.

 

Retatrutide (LY-3437943) is a synthetic triple-receptor agonist peptide that Durham Peptides supplies as research-grade 10 mg lyophilized vials, stocked and shipped domestically for researchers across Canada. It acts on three metabolic pathways at once — GLP-1, GIP, and glucagon — and is sometimes informally called “GLP-3” for this three-receptor mechanism.

Because it engages an additional glucagon pathway beyond dual-agonist compounds, retatrutide is frequently studied alongside Semaglutide (a mono-agonist) and Tirzepatide (a dual-agonist) to compare multi-receptor pharmacology. Durham Peptides stocks all three for comparative research.

BENEFITS/Retatrutide Peptide Canada

• Triple receptor activation — studied for simultaneous GLP-1, GIP, and glucagon engagement

• Metabolic research — explored in Phase 2 clinical trials with notable body-composition results

• Glucagon component — linked to thermogenesis and energy-expenditure pathways

• Next-generation compound — investigated as an advancement over dual-agonist approaches

• Comparative pharmacology — assessed alongside mono- and dual-agonists in research settings

WHAT RESEARCHERS LOOK AT

• Triple-agonist binding affinity across GLP-1, GIP, and glucagon receptors

• Additive effects of glucagon-receptor activation on energy expenditure

• Dose-response and tolerability profiling from clinical-trial data

• Comparative outcomes vs tirzepatide and semaglutide

• Pharmacokinetic profiling and receptor selectivity

QUICK SPECS

• Form: Lyophilized peptide powder

• Net per vial: 10 mg

• Purity: ≥99% (HPLC verified)

• Identity: MS-verified (per COA)

• Storage: 2–8°C, protect from light and moisture

• Reconstitution: Use bacteriostatic water (sold separately)

IDENTITY BASICS

• CAS: 2381089-83-2

• Classification: Triple GLP-1/GIP/glucagon receptor agonist